奧布替尼(宜諾凱®)為一款處於後期臨床階段、具有潛在同類最佳優勢的高中樞神經係統滲透性、選擇性、不可逆口服
百利天恒:BL-ARC001用於在晚期實體瘤治療獲得臨床試驗批準通知書百利天恒公告稱
Read MoreThere are many variations of passages of Lorem Ipsum available, but the majority have suffered alteration in some form, by injected humour.
There are many variations of passages of Lorem Ipsum available, but the majority have suffered alteration in some form, by injected humour.